A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis
- Srdan Verstovsek
- , Michael R. Savona
- , Ruben A. Mesa
- , Hua Dong
- , Julia D. Maltzman
- , Shringi Sharma
- , Jeffrey Silverman
- , Stephen T. Oh
- , Jason Gotlib
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Bursky Center for Human Immunology and Immunotherapy
- Division of Hematology
- Department of Medicine
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Molecular Cell Biology
- DBBS - Immunology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
47
Link opens in a new tab
Scopus
citations